A novel tissue-engineered decellularized and re-endothelialized human vascular graft for use in arterial bypass grafting.

Principal Investigator

Cristina Castells Sala

File

CPP2021-008438

Duration

2022 – 2025

Funded by

Agencia Estatal de Investigación

Funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR.

Objective

Development of a biological substitute of human origin for use as a revascularization graft, the VasCraft bioimplant, in coronary bypass surgeries